Francisco David 4
4 · Organogenesis Holdings Inc. · Filed Feb 18, 2026
Research Summary
AI-generated summary of this filing
Organogenesis (ORGO) CFO Francisco David Withholds 52,448 Shares
What Happened
CFO Francisco David surrendered/withheld a total of 52,448 ORGO shares on 2026-02-15 to satisfy tax liabilities and/or exercise-price obligations. The four withholding dispositions were at $3.73 per share (3,898; 21,412; 13,369; 13,769 shares), with line values of $14,540, $79,867, $49,866 and $51,358 respectively — about $195,631 in aggregate. These were tax/exercise-related withholdings (Form 4 code “F”), not open-market sales.
Key Details
- Transaction date: 2026-02-15; Form 4 filed: 2026-02-18 (appears filed within required business-day window).
- Price per share: $3.73; total shares withheld: 52,448; total value ≈ $195,631.
- Line-item disposals: 3,898; 21,412; 13,369; 13,769 shares (see values above).
- Transaction code: F = payment of exercise price or tax liability (withholding).
- Shares owned after transaction: not specified in the provided filing excerpt.
- No 10b5-1 plan or other special instructions disclosed in the provided details.
Context
This appears to be a routine tax-withholding/cashless step tied to option exercises or award vesting — common for executives and not a market sell signal. For retail investors, purchases or open-market buys are generally more indicative of bullish insider sentiment; withholdings to cover taxes are administrative and frequently occur after exercises or vesting events.
Insider Transaction Report
- Tax Payment
Class A Common Stock
2026-02-15$3.73/sh−3,898$14,540→ 555,197 total - Tax Payment
Class A Common Stock
2026-02-15$3.73/sh−21,412$79,867→ 533,785 total - Tax Payment
Class A Common Stock
2026-02-15$3.73/sh−13,369$49,866→ 520,416 total - Tax Payment
Class A Common Stock
2026-02-15$3.73/sh−13,769$51,358→ 506,647 total